Distribution of plasma α1-antichymotrypsin levels in Alzheimer disease patients and controls and their genetic controls

Neurobiology of Aging

Volumn 23, Issue 3, 2002, Pages 377-382

  Wang, Xiaoyan ^a   DeKosky, Steven T ^b   Ikonomovic, Milos D ^b   Ilyas Kamboh, M ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

1 antichymotrypsin; Alzheimer's disease; Genetics; Plasma level

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD ANALYSIS; CLINICAL TRIAL; CODON; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENDER; GENETIC ANALYSIS; GENETIC REGULATION; GENETIC VARIABILITY; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN POLYMORPHISM;

AGED; AGED, 80 AND OVER; ALPHA 1-ANTICHYMOTRYPSIN; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; CODON; DNA MUTATIONAL ANALYSIS; FEMALE; GENOTYPE; HUMANS; INTRONS; MALE; MIDDLE AGED; NORMAL DISTRIBUTION; PATIENTS; POLYMORPHISM, GENETIC;

EID: 0036230087     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(01)00322-0     Document Type: Article

References (39)

1. 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease
2. 1-antichymotrypsin in brain dysfunction and injury
3. Ueber eine eigenartige erkrankung der hirnrinde
4. 1-antitrypsin genes
5. 1-antichymotrypsin
6. 1-antitrypsin, and antithrombin III
7. 1-antichymotrypsin A allele in Alzheimer's disease
8. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported
9. 1-antichymotrypsin gene polymorphism, and risk for Alzheimer's disease in the Spanish population
10. 1-antichymotrypsin in Alzheimer disease
11. 1-antichymotrypsin polymorphism, apolipoprotein E and patients with late-onset Alzheimer's disease
12. 1-antichymotrypsin level in cerebrospinal fluid is closely associated with late onset Alzheimer's disease
13. 1-antichymotrypsin polymorphisms with Alzheimer's disease: A report on autopsy-confirmed cases
14. 1-antichymotrypsin polymorphism
15. Variation of the alpha1-antitrypsin level of plasma
16. 1-antichymotrypsin is increased in cerebrospinal fluid and serum of patients with probable Alzheimer disease
17. 1-antichymotrypsin level as a marker for Alzheimer-type dementia
18. 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments
19. 1-Antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia
20. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease
21. 1-antichymotrypsin enhances Alzheimer-like pathology in amyloid protein precursor transgenic mice
22. Lack of association between alpha 1-antichymotrypsin polymorphism, Alzheimer's disease, and allele ε4 of apolipoprotein E
23. 1-antichymotrypsin gene polymorphism, and risk for Alzheimer's disease
24. 1-antichymotrypsin A allele and Alzheimer's disease
25. 1-antichymotrypsin polymorphism in Alzheimer's disease
26. 1-antichymotrypsin promotes β-sheet amyloid plaque deposition in a transgenic mouse model of Alzheimer's disease
27. Effect of cytokines, dexamethazone and the A/T-signal peptide polymorphism on the expression of alpha1-antichymotrypsin in astrocytes: Significance for Alzheimer's disease
28. 1-Antichymotrypsin, and IL-1 beta are not increased in CSF or serum in Alzheimer's disease
29. 1-antichymotrypsin allele associated with familial obstructive lung disease
30. 1-antichymotrypsin gene and chronic lung disease
31. Polymorphism in AACT gene may lower age of onset of Alzheimer's disease
32. 1-antichymotrypsin bi-allele polymorphism, apolipoprotein-E tri-allele polymorphism, and genetic risk of Alzheimer's syndrome
33. Human plasma proteinase inhibitors
34. 1-antichymotrypsin variant detected by PCR-single strand conformation polymorphism (PCR-SSCP), and direct sequencing
35. 1-antichymotrypsin in patients with occlusive-cerebrovascular disease
36. 1-antichymotrypsin as a risk modifier for late-onset Alzheimer's disease in Japanese apolipoprotein E epsilon 4 allele carriers
37. 1-antichymotrypsin polymorphism in Japanese cases of Alzheimer's disease